Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial(Nature Medicine, 10.1038/s41591-024-03261-7)
Research output: Contribution to specialist publication › Corrections (errata and retractions) › peer-review
Contributors
- Department of Gynecology and Obstetrics
- Ludwig Maximilian University of Munich
- Hospital Universitario 12 de Octubre
- University of Liege
- University of Hamburg
- Tokai University
- IRCCS Istituto Europeo di Oncologia - Milano
- Medical University of Vienna
- University of Basel
- St Vincent's University Hospital
- University College Cork
- Royal North Shore Hospital
- Beata María Ana Hospital
- Hospital Ramon y Cajal
- University of Padua
- IRCCS Istituto Oncologico Veneto - Padova
- IRCCS Hospital San Raffaele - Milano
- Vita-Salute San Raffaele University
- KU Leuven
- AstraZeneca
- Dana-Farber Cancer Institute
- Duke University
- University of Edinburgh
- University of Lausanne
- Cantonal Hospital Luzern
- Ente Ospedaliero Cantonale (EOC)
- Sahlgrenska University Hospital
- Lund University
- Uppsala University
- Hospital de Basurto
- Hospital Universitario Marques de Valdecilla
- Hospital Universitario Virgen de las Nieves
- Hospital Clínico Universitario de Salamanca
- University of Santiago de Compostela
- Hospital Ruber Internacional
- Hospital Universitario Virgen del Rocio
- Hospital Universitario de la Princesa
- University Hospital of Bellvitge
- Hospital Clinic of Barcelona
- Saint Mary's Hospital
- Champalimaud Foundation
- University of Porto
- Centralny Szpital Kliniczny Wojskowej Akademii Medycznej z Poliklinika
- University Clinical Center Gdansk
- Opolskie Centrum Onkologii im. prof. T. Koszarowskiego
- Maria Sklodowska-Curie Institute of Oncology
- Krakow University Hospital
- University Hospital Carl Gustav Carus Dresden
Abstract
Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-024-03261-7, published online 13 September 2024. In the version of this article initially published, members of the DESTINY-Breast12 study group were not included by the journal in the full text. In Table 1, under the “Prior CNS therapies n (%)” section, seven rows have been added, in addition to the original CNS radiotherapy, WBRT and SRS rows. In Table 1 and in the Results: Patients section, “intracranial therapy” has been amended to “CNS radiotherapy,” while the text “the type of intracranial radiotherapy was not always recorded by investigators, and only WBRT and SRS intracranial radiotherapy were reported” has been removed. All changes appear in the HTML and PDF versions of the article.
Details
Original language | English |
---|---|
Pages | 3780 |
Number of pages | 1 |
Volume | 30 |
Issue number | 12 |
Journal | Nature medicine |
Publication status | Published - Dec 2024 |
Peer-reviewed | Yes |
External IDs
PubMed | 39653780 |
---|